Henry Sacks

  • PROFESSOR Preventive Medicine
  • PROFESSOR Medicine, Infectious Diseases
  • PROFESSOR Oncological Sciences
  • PROFESSOR Pediatrics
  • PROFESSOR Biomathematical Sciences
  • PROFESSOR Geriatrics and Palliative Medicine
Print ProfilePrint Profile

Email

Specialty

Certifications

  • Geriatric Medicine

  • Infectious Disease

  • American Board of Internal Medicine

Training Areas

Education

  • MD, Albany Medical College

  • Ph.D., Albany Medical College

  • Internship, General Medicine
    University of Connecticut

  • Residency, Internal Medicine
    University of Connecticut

  • Fellowship, Infectious Diseases
    University of Connecticut

Biography

    Dr. Sacks is the Director of the Thomas C. Chalmers Clinical Trials Unit.

Research

Dr. Sacks originally came to Mount Sinai to work with Thomas C. Chalmers, a pioneer in what is now called "evidence-based medicine." His work has been in two categories: 1) the design, conduct and analysis of clinical and natural history studies (primary studies), to provide new data to directly answer clinical questions, and 2) synthesis of existing data by meta-analysis, decision analysis and cost-effectiveness analysis, to provide guidance for urgent clinical problems for which primary data are not (or not yet) available. Dr. Sacks' current research interests include clinical trials, infections in the elderly, HIV, complementary and alternative therapies.

Dr. Sacks is also Director for Clinical Research of Mount Sinai's Complementary and Alternative Medicine (CAM) Center, and co-director of Mount Sinai's Fogarty International AIDS Training program.

Publications

Dunn AS, Wisnivesky J, Ho W, Moore C, Mcginn T, Sacks HS. Perioperative management of patients on oral anticoagulants: a decision analysis. Med Decis Making 2005 Jul-Aug;: 387-397.

Rovetto AL, Lai CY, Sacks H. Cost-Effectiveness of Probiotic Treatment in Preventing Hospital-Acquired Clostridium Difficile-Associated Diarrhea.;.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Sacks during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.

  • Wyeth (Pfizer, Inc.)

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

19 East 98th Street Room Suite 4B
New York, NY 10029

Tel: 212-241-7856
Fax: 212-860-4607
19 East 98th Street

19 East 98th Street
Infectious Disease Associates
New York, NY 10029

Tel: 212-241-7856
Fax: 212-860-4607
Get Directions

Office Hours:
  • Monday 9:00am - 5:00pm
  • Tuesday 12:00pm - 5:00pm
  • Wednesday 9:00am - 5:00pm
  • Thursday 9:00am - 5:00pm
  • Friday 9:00am - 12:00pm